SUBSCRIBE
SUBSCRIBE
News   Drug Development

Vertex Pharmaceuticals (MA), Johnson & Johnson Hepatitis C Drug Works After Others Fail Like Merck & Co., Inc.'s Boceprevir

September 8, 2010 | 
1 min read
Bloomberg -- Vertex Pharmaceuticals Inc.’s most advanced experimental drug, in development with Johnson & Johnson, worked in patients with hepatitis C who didn’t respond to other treatment, a study found.
Clinical research Phase 3
Johnson & Johnson Family of Companies Merck & Co. Vertex Pharmaceuticals
MORE ON THIS TOPIC
Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Human liver organ and pills. World hepatitis day. National liver health awareness month. Liver transplantation, donation background. Save patient life in hospital with liver transplant
Postmarket research
Update: Reversal after 20 deaths allows new Japan patients to take Amgen’s rare disease drug Tavneos
May 21, 2026
 · 
3 min read
 · 
Tristan Manalac
Crowd silhouettes reach toward a raised trophy beneath a vivid sunset sky, showing shared ambition, victory, teamwork, celebration, and success with open space for text.
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
May 21, 2026
 · 
3 min read
 · 
Annalee Armstrong
Fight versus pop art comic red blue background with halftone, rays, hands holding paper. Vector cartoon illustration in retro style. Design for comic book, poster, banner, competition
Leadership
Vaxart seeks shareholder support as battle over stock split brews
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac